Novel antifungals set for market introduction
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Strategy
Covid-19 and the future of diagnostics
Interviewee/Contributor
Neelam Patel
Organisation
MedCity
A new strategy for regenerating damaged tissue
Interviewee/Contributor
Tim Knotnerus
Organisation
AgomAb Therapeutics NV
Leyden Labs plans to protect against viral infections
Interviewee/Contributor
Koenraad Wiedhaup
Organisation
Leyden Laboratories BV
How exchange traded funds could benefit Europe
Interviewee/Contributor
Chris Maggos
Organisation
LifeSci Advisors
New technologies boost drug repurposing
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
The Bispecific Approach, Interviews with Merus, Genmab and NovalGen
Interviewee/Contributor
Bill Lundberg, Tahamtan Ahmadi and Amit Nathwani
Organisation
MedNous
Purespring to develop gene therapies for the kidney
Interviewee/Contributor
Richard Francis
Organisation
Purespring Therapeutics Ltd
Forbion to create and grow biotech companies
Interviewee/Contributor
Sander Slootweg and Juliette Audet
Organisation
Forbion
Real world evidence is changing regulatory policy
Interviewee/Contributor
Marie Manley and Zina Chatzidimitriadou
Organisation
Sidley Austin LLP